3Calles-Escandon J,Mirza SA,Sobel BE,et al.Induction of hyperinsulinemia combined with hyperglycema and hypertriglyceridemia increase plasminogen activator inhibitor 1 in blood in normal human subjects. Diabetes, 1998,47:290. 被引量：1
4Ginsberg HN.Insulin resistance and cardiovascular disease.J Clin Invest,2000,106:453. 被引量：1
5Adelman R.Obesity and renal disease.Curr Opin Nephrol Hyperten,2002,11:331-335. 被引量：1
6Chagnac A, Weinstein T, Korzets A.Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol,2000,278(5):817-822. 被引量：1
9Goldstein BJ.Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol,2002,90(5A):3-10. 被引量：1
10Groop LC.Insulin resistance:the fundamental trigger of type 2 diabetes.Obesity and metabolism,1999,1:2-9. 被引量：1
二级参考文献24
1[1]Leehey DJ,Singh AK,Alavi N, et al.Role of angiotensionⅡin diabetic nephropathy. Kidney Int,2000,58(Suppl 77):93-98. 被引量：1
2[2]Mclennan SV,Kelly DJ,Cox AJ,et al.Decreased matrix degradation in diabetic nephropathy:effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia,2002,45(2):268-275. 被引量：1
3[3]Mclennan SV, Fisher E, Martell SY, et al. Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy. Kidney Int, 2000, 58(Suppl 77): 81-87. 被引量：1
4[4]John M, Lisa E, Malcoln D, et al. Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix. J Am Soc Nephrol,2001,12(1):88-96. 被引量：1
5[5]Burns KD. Angiotension Ⅱ and its receptors in the diabetic kidney. Am J Kidney Dis, 2000,36(3): 449-467. 被引量：1
6[6]Fornoni A, Striker LJ, Zheng F, et al. Reversibility of glucose-induced changes in mesangial cell extracellular matrix depends on the genetic background.Diabetes,2002,51(2):499-505. 被引量：1
7Weisinger JR, Kempson RL, Eldridge FL, et al. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med,1974,81: 440-447. 被引量：1
8Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant, 2001, 16:1790-1798. 被引量：1
9Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int, 2001, 59:1498 - 1509. 被引量：1
10Adelman R. Obesity and renal disease. Curr Opin Nephrol Hyperten, 2002, 11: 331-335. 被引量：1
